Elicio Therapeutics, Inc. (ELTX)

Elicio Therapeutics Statistics

Total Valuation

ELTX has a market cap or net worth of $163.04 million. The enterprise value is $158.36 million.

Market Cap	163.04M
Enterprise Value	158.36M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ELTX has 17.48 million shares outstanding. The number of shares has increased by 35.90% in one year.

Current Share Class	17.48M
Shares Outstanding	17.48M
Shares Change (YoY)	+35.90%
Shares Change (QoQ)	+3.94%
Owned by Insiders (%)	32.52%
Owned by Institutions (%)	14.87%
Float	11.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	41.43
P/TBV Ratio	42.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.29, with a Debt / Equity ratio of 3.95.

Current Ratio	3.29
Quick Ratio	3.16
Debt / Equity	3.95
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-41.11

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-79.40%
Return on Invested Capital (ROIC)	-204.09%
Return on Capital Employed (ROCE)	-194.53%
Revenue Per Employee	n/a
Profits Per Employee	-$1.43M
Employee Count	32
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +84.75% in the last 52 weeks. The beta is 2.08, so ELTX's price volatility has been higher than the market average.

Beta (5Y)	2.08
52-Week Price Change	+84.75%
50-Day Moving Average	9.81
200-Day Moving Average	8.46
Relative Strength Index (RSI)	54.03
Average Volume (20 Days)	106,014

Short Selling Information

The latest short interest is 914,870, so 5.24% of the outstanding shares have been sold short.

Short Interest	914,870
Short Previous Month	749,923
Short % of Shares Out	5.24%
Short % of Float	7.76%
Short Ratio (days to cover)	8.66

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-42.35M
Pretax Income	-45.86M
Net Income	-45.86M
EBITDA	-42.11M
EBIT	-42.35M
Earnings Per Share (EPS)	-$3.09

Balance Sheet

The company has $20.61 million in cash and $15.06 million in debt, giving a net cash position of $5.55 million or $0.32 per share.

Cash & Cash Equivalents	20.61M
Total Debt	15.06M
Net Cash	5.55M
Net Cash Per Share	$0.32
Equity (Book Value)	3.82M
Book Value Per Share	0.22
Working Capital	14.95M

Cash Flow

In the last 12 months, operating cash flow was -$38.90 million and capital expenditures -$45,000, giving a free cash flow of -$38.94 million.

Operating Cash Flow	-38.90M
Capital Expenditures	-45,000
Free Cash Flow	-38.94M
FCF Per Share	-$2.23

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ELTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.90%
Shareholder Yield	-35.90%
Earnings Yield	-27.98%
FCF Yield	-23.76%

Analyst Forecast

The average price target for ELTX is $13.00, which is 39.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	39.34%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-26.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2